跳至主要内容
临床试验/JPRN-UMIN000023578
JPRN-UMIN000023578招募中未知

ong-term maintenance of anti-tumor immune responses by vaccination with tri-WT1 peptide cancer vaccine WT1 Trio - Long-term anti-tumor immune responses by WT1 Trio

Osaka University Graduate School of Medicine Dept. Cancer Immunotherapy0 个研究点目标入组 90 人开始时间: 2016年9月10日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
16years-old 至 85years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1 A patient with active infectious disease. 2 A patient who experienced SAE (grade >=4) in the previous clinical trial of WT1 peptide vaccine 3 A patient with severe complication or complications. 4 A patient with severe mental disorder. 5 A patient who participates in any other clinical trial 6 A patient who should not be recruited to the clinical trial as determined by the investigators

研究者

发起方
Osaka University Graduate School of Medicine Dept. Cancer Immunotherapy

相似试验